Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0369819970270010011
Jorunal of Korean Pharmaceutical Sciences
1997 Volume.27 No. 1 p.11 ~ p.14
Comparison of Diclofenac Sodium and Diclofenac Sodium - ¥â - cyclodextrin Complexation on Gastric Mucosal Injury in Rats
¹ÚÀçÈÆ/Park JH
±èÁ¾È¯/±èÁÖÀÏ/±è½ÂÁ¶/¼­¼ºÈÆ/ÀÌ°æÅÂ/Kim JH/Kim JI/Kim SJ/Seo SH/Lee KT
Abstract
This laboratory has recently reported the solubility and in vivo absorption enhancement of diclofenac sodium by ¥â?cyclodextrin complexation. The acute gastroduodenal mucosa injury provoked by administration of 34 mg/kg and 68 mg/kg of a diclofenac sodium (DS) and equivalent dose of new formulation [diclofenac sodium-beta-cyclodextrin complexation(DS?¥â?CD)] was evaluated and compared. Microscopic examinations, performed after 18-hrs treatment, demonstrated that DS?¥â?CD was less gastrolesive than DS. The drop in gastrophy after a single dose of the assigned drug was considerably greater for DS than for DS?¥â?CD, which registered similar values to control. Since gastrophy is an expression of the anatomy-functional integrity of the gastric barrier, the results indicate that DS?¥â?CD exerts less direct acute damage on the gastric mucosa. Therefore, when administered short-term, DS?¥â?CD appears to be less gastrolesive than the standard DS formulation.
KEYWORD
Diclofenac sodium, ¥â?cyclodextrin, Absorption, Complexation, Mucosal injury
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)